Time(ICT) HALL A
08:20-08:30 Welcome note: AHAD-AP ASM 2023
Alok Srivastava, Christian Medical College Vellore, Vellore.
Darintr Sosothikul, Chulalongkorn University, Bangkok.
Co-Presidents AHAD-AP ASM 2023
08:30-09:10 Plenary 1
Chair: Alok Srivastava, Christian Medical College Vellore, Vellore.
08:30-09:00 Extended half-life CFCs and theirimpact on haemophilia care
Speaker: Flora Peyvandi, University of Milan, Milan.
09:00-09:10 Discussion
Hall A Hall B
09:15-10:45 Scientific Session 1a
Theme: Prophylaxis – CFC
Chair: Joyce Lam Ching Mei, KK Women's and Children's Hospital, Singapore.		 Scientific Session 1b
Theme: Lab diagnosis
Chair: Tien Sim Leng, Singapore General Hospital, Singapore. Wong Wan Hui,Singapore General Hospital, Singapore.
09:15-09:45 Initiating prophylaxis in young children – when and how ?
Speaker: Seungmin Hahn, Yonsei University College of Medicine, Seoul.		 Challenges with the Laboratory Diagnosis of Bleeding Disorders
Speaker: Tien Sim Leng, Singapore General Hospital, Singapore
09:45-10:15 Clinical Outcomes of Prophylaxis with Low-Dose Pharmacokinetic-Guided Extended Half Life Factor VIII Concentrates
Speaker: Darintr Sosothikul, Chulalongkorn University, Bangkok.		 Recovery assays and limitations – SHL / EHL
Speaker: Yingyong Chinthamitr, Siriraj hospital, Bangkok.
10:15-10:45 Optimizing Prophylaxis in Resource-Challenged Settings
Speaker:NguyenThi Mai, National Institute of Hematology and Blood Transfusion, Hanoi.		 Lab monitoring for surgery withnon-CFC products
Speaker: Nitty Mathews, Christian Medical College Vellore, Vellore.
10:45-11:15 Tea Break
11:15-12:30 Scientific Session 2a
Theme: Inhibitors in Haemophilia
Chair: Runhui Wu, Children’s Hospital, Capital Medical University, Beijing.		 Scientific Session 2b
Theme: Using registries to improve haemophilia care
Chair: Shashikant Apte, Sahyadri Specialty Hospital, Pune.
11:15-11:40 Prevalence of inhibitors – How toenhance surveillance?
Speaker: Ng HengJoo, Singapore General Hospital, Singapore.		 National registries
Speakers: Japan: Takeshi Matsumoto, Mie University Hospital, Mie Prefecture.
Thailand: Ampaiwan Chuansumrit, Ramathibodi Hospital, Bangkok.
11:40-12:05 Immune Tolerance Therapy for Inhibitors – An Asian Perspective
Speaker: Li Zekun, Children's Hospital, Capital Medical University Beijing.		 Nation Registries
Speakers: South Korea- Jung Woo Han, Yonsie University Health System, Seoul.
Australia- HuyenTran, The Alfred hospital & Monash Medical Centre, Melbourne.
12:05-12:30 Prevention of Bleeds in Persons with Haemophilia with Inhibitors
Speaker:Renchi Yang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin.		 APBDR
Speaker: Azusa Nagao, Ogikubo Hospital, Tokyo.
12:30-13:00 Lunch
13:00-14:00 Sponsored Symposium I- Sanofi Sponsored Symposium II- Roche
Hall A
14:00-14:40 Plenary 2
Chair: Darintr Sosothikul, Chulalongkorn University, Bangkok.
14:00-14:30 Addressing the diagnostic gap in haemophilia and other inherited bleeding disorders - what are the possibilities?
Speaker: Keith Gomez, Royal Free Hospital, London.
14:30-14:40 Discussion
Hall A Hall B
14:45-16:15 Scientific Session 3a – Women with Bleeding Disorders
Chair: Chean Sophal, National Pediatric Hospital, Phnom Penh.		 Scientific Session 3b – Nursing
Chair: Lim Chiew Ying, KK Women’s and Children’s Hospital, Singapore.
14:45-15:15 Womenwith Bleeding Disorders – Diagnostic Issues
Speaker:Tan Chuen Wen, Singapore General Hospital, Singapore.		 Nursing principles of care- bleeding disorders
Speaker: Jamie Chase, John Hunter Childrens Hospital, New South Wales.
15:15-15:45 Management of Menorrhagia in Women with Bleeding Disorders
Speaker: Bundarika Suwanawiboon, Siriraj Hospital, Bangkok.		 Panel Discussion- Role of Haemophilia Nurse in HTCs across Asia Pacific.
Moderator: Abraham Sunder Singh, Christian Medical College, Vellore.
Panelists:
1.Yeam Shin Yen, Singapore General Hospital, Singapore.
2.Pakawan Wongweerawattanakoon, Ramathibodi Hospital, Bangkok.
3.Devika Danekhu, Civil Service Hospital, Kathmandu.
15:45-16:15 Management of Pregnancies and Surgeries in Women with Bleeding Disorders
Speaker: Briony Cutts, Royal Women's hospital Melbourne.		 Training and preparation of a familyfor self-infusion at home.
Speaker: Wu Siting, BeijingChildren's Hospital, Beijing.
16:30-17:00 Moderated poster session with tea
Moderators: Tien SimLeng, Singapore General Hospital, Singapore Rungrote Natesirinilkul, Chiang Mai University, Chiang Mai.
Hall A Hall B
17:00-18:15 Scientific Session 4a – Surgery in haemophilia
Chair: Hideyuki Takedani, National Hospital Organization Tsuruga Medical Center, Fukui.		 Scientific Session 4b – MSK Outcome assessment including PROs
Chair: Judy AnnDavid, Christian Medical College, Vellore.
17:00-17:25 Management of Dental Procedures in Patients with Haemophilia
Speaker: Thanaporn Thongjood, Ramathibodi Hospital, Bangkok.		 MSK Outcomes assessment- Overview
Speaker: Tachit Jiravichitchai, Ramathibodi Hospital, Bangkok.
17:25-17:50 Perioperative haemostasis managementin haemophilia
Speaker: Jae Joon Han, Kyung Hee University, Seoul.		 MSK outcome assessment– what is practical.
Speakers:
a) Taiwan: Yeu-Chin Chen, Tri-Service General Hospital, Taipei.
b) Indonesia: Rizky Kusumawardhani, Dr. Cipto Mangunkusumo Hospital, Jakarta.
5 mins Q&A
c) India: Naveen Cherian Thomas, Christian Medical College, Vellore.
d) Malaysia: Haishini Mageswaran, Hospital Ampang, Ampang.
5 mins Q&A
17:50-18:15 Joint replacement surgery inhaemophilia – What considerations?
Speaker: Shashikant Apte, Sahyadri Specialty Hospital, Pune.
18:15-19:15 Sponsored symposium III with high tea - Takeda Sponsored symposium IV with high tea - Chugai
19:30 Dinner with Invited guests
Time(ICT) HALL A
08:30-09:10 Plenary 3
Chair: Pantep Angchaisuksiri, Ramathibodi Hospital, Bangkok.
08:30-09:00 Non-CFC products for haemophilia –how will they change the management paradigm?
Speaker: Johnny Mahlangu, University of the Witwatersrand, Johannesburg.
09:00-09:10 Discussion
Hall A Hall B
09:15-10:45 Scientific Session 5a – Use of Non-CFC haemostasis products
Chair: Ampaiwan Chuansumrit, Ramathibodi Hospital, Bangkok.		 Scientific Session 5b – Comprehensive Management
Chair: Alison Street, Monash University, Melbourne.
09:15-09:45 Emicizumab – Real world data -Standard & Alternative doses
Speaker: Keiji Nogami, Nara Medical University, Nara.		 Role of WFH in the comprehensive management of haemophilia in the Asia Pacific.
Speakers: Toong Youtananukorn, World Federation of Hemophilia, Montreal.
Hazri Aris, World Federation of Hemophilia, KualaLumpur.
09:45-10:15 The ‘Universal’ haemostasis productsfor haemophilia A/B with and without inhibitors – What can be their impact?
Speaker: Alok Srivastava, Christian Medical College Vellore, Vellore.		 Ultrasoundin clinical decision making - Perspectives & Application
Speaker:Madhavi Kandagaddala, Christian Medical College Vellore, Vellore.
10:15-10:45 Management of Breakthrough Bleeds and Surgery in the Era of Non-CFC Products.
Speaker: Jiaan-Der Wang, Taichung Veterans General Hospital, Taichung.		 Patient Empowerment – Are we doing enough ?
Speaker: Ekawat Suwantaroj, Bangkok.
10:45-11:15 Tea Break
Hall A Hall B
11:15-12:25 Scientific Session 6a – Scientific Abstracts- Physicians and Lab
Moderators: M Joseph John, Christian Medical College, Ludhiana.
Patcharee Kamwilaisak, Khon Kaen University, Khon Kaen.		 Scientific Session 6b – Scientific Abstracts- Nursing and MSK
Moderators: Judy AnnDavid, Christian Medical College, Vellore
Anjalin D’Souza, Manipal Academy of Higher Education, Manipal
11:15-11:20 Introduction Introduction
11:20-11:30 Role of Low Dose prophylaxis of Anti Hemophilic Factor in Haemophilia.
Presenter: Sudipta Nandi, Maulana Azad Medical College, New Delhi.		 Effectiveness of Myofascial therapy (MFT) and Conventional physiotherapy (CPT) with intermittent prophylaxis on Joint Health in Haemophilic Arthropathy- A Proof of Concept Randomized Control Trial.
Presenter: Diksha Sarwan, Christian Medical College and Hospital, Ludhiana.
11:30-11:40 Successful removal of high titer inhibitor in a patient with severe haemophilia A by low dose rituximab combined with low dose FVIII immune tolerance therapy.
Presenter: Li Zhou, The Second Affiliated Hospital of Anhui Medical University, Anhui.		 Estimated cost per bleed saved: On-Demand (OD) versus Low-dose Prophylaxis (LDP) for Indonesian children with Severe Haemophilia A (SHA).
Presenter: Christina Hill-Zabala, Grifols Asia Pacific, Singapore.
11:40-11:50 Barriers to cascade screening and prenatal testing in families with inherited bleeding disorders.
Presenter: Archit Sunil Pandharipande, Post Graduate Institute of Child Health, Noida.		 Out-of-pocket expenditure incurred during treatment of Haemophilia at a government facility in North India.
Presenter: Manju Singh, Post Graduate Institute of Child Health, Noida.
11:50-12:00 Managing surgical procedures in children with inherited bleeding disorders; a single center experience.
Presenter: Eby P Baby, Post Graduate Institute of Child Health, Noida.		 Burden of Care and Quality of Life Among Caregivers of Filipino Children with Haemophilia Before and During the COVID-19 Pandemic: A Cross-Sectional Study.
Presenter: Noah Sacluti, University of Santo Tomas Hospital, Manila.
12:00-12:10 Management of severe haemophilia with inhibitors to factor VIII with recurrent retroperitoneal bleed.
Presenter: Vijayshree Muthukumar, Apollo Hospital, Chennai.		 Rehabilitation for the improvement of functional status in hemophiliacs.
Presenter: Sudipta Nandi, Maulana Azad Medical College, New Delhi.
12:10-12:20 Validation test for Haemophilia self-screening tool In South Kalimantan, Indonesia.
Presenter: Wulandewi Marhaeni, Universitas Lambung Mangkurat, South Kaimantan.		 Sufferings beyond the Physical impact of Haemophilia- A mixed method study on personal, social, economic domains and its association with quality of life in patients with haemophilia (PWH) and their caregivers (WE CARE)
Presenter: Shivani Bhanwra, Christian Medical College and Hospital, Ludhiana.
12:20-12:25 Conclusion Conclusion
12:30-13:00 Lunch
13:00-14:00 Sponsored Symposium V - Novo Nordisk
Hall A
14:00-14:40 Plenary 4
Chair: Ponlapat Rojnuckarin, Chulalongkorn University, Bangkok
14:00-14:30 Radiological assessment of joint –what is possible and what is useful ?
Speaker: Andrea S Doria, The Hospital for Sick Children, Toronto.
14:30-14:40 Discussion
Hall A
14:45-15:45 Scientific Session 7 – Country/Region Presentations
Chair: Theera Ruchutrakool, Siriraj Hospital, Bangkok.
Haemophilia Care
Cambodia: Chean Sophal, National Pediatric Hospital, Phnom Penh.
China: Guoqing Liu, Beijing Children's Hospital, Beijing.
Sri Lanka: Visaka Ratnamalala, National Hospital of Sri Lanka, Colombo.
Bangladesh: Akhil Ranjon Biswas, Dhaka Medical College, Dhaka.
Philippines: Flerida Hernandez, University of Santo Tomas, Manila.
Myanmar: Aye Aye Khaing, Yangon Children Hospital, Yangon.
15:45-16:15 Education and Training - Role of AHAD-AP
Speaker: Alison Street, Monash University, Melbourne.
16:15-17:00 Scientific Session 8 – Hot Topics (Industry presentations)
Chair: Nongnuch Sirachainan, Ramathibodi Hospital, Bangkok.
16:15-16:30 Concizumab prophylaxis in patients with haemophilia A or B without inhibitors: Efficacy and safety results from the primary analysis of the phase 3 explorer8 study.
Speaker: Myriam Dardikh, Novo Nordisk, Dubai.
16:30-16:45 A Phase 3 study (ATLAS-PPX) to evaluate efficacy and safety of fitusiran, an siRNA therapeutic, in people with hemophilia A or B who have switched from prior factor or bypassing agent prophylaxis.
Speaker: Alok Srivastava, Christian Medical College Vellore, Vellore.
16:45-17:00 Phase 3 prospective, randomized, controlled, open-label, multicenter, crossover study of recombinant ADAMTS13 in patients with congenital thrombotic thrombocytopenic purpura.
Speaker: Laura Ochoa, Takeda, Singapore.
17:15-17:30 Closing session
×
×
×
×
×
Time(ICT) HALL A
08:20-08:30 Welcome note: AHAD-AP ASM 2023
Alok Srivastava, Christian Medical College Vellore, Vellore.
Darintr Sosothikul, Chulalongkorn University, Bangkok.
Co-Presidents AHAD-AP ASM 2023
08:30-09:10 Plenary 1
Chair: Alok Srivastava, Christian Medical College Vellore, Vellore.
08:30-09:00 Extended half-life CFCs and theirimpact on haemophilia care
Speaker: Flora Peyvandi, University of Milan, Milan.
09:00-09:10 Discussion
Hall A Hall B
09:15-10:45 Scientific Session 1a
Theme: Prophylaxis – CFC
Chair: Joyce Lam Ching Mei, KK Women's and Children's Hospital, Singapore.		 Scientific Session 1b
Theme: Lab diagnosis
Chair: Tien Sim Leng, Singapore General Hospital, Singapore. Wong Wan Hui,Singapore General Hospital, Singapore.
09:15-09:45 Initiating prophylaxis in young children – when and how ?
Speaker: Seungmin Hahn, Yonsei University College of Medicine, Seoul.		 Challenges with the Laboratory Diagnosis of Bleeding Disorders
Speaker: Tien Sim Leng, Singapore General Hospital, Singapore
09:45-10:15 Clinical Outcomes of Prophylaxis with Low-Dose Pharmacokinetic-Guided Extended Half Life Factor VIII Concentrates
Speaker: Darintr Sosothikul, Chulalongkorn University, Bangkok.		 Recovery assays and limitations – SHL / EHL
Speaker: Yingyong Chinthamitr, Siriraj hospital, Bangkok.
10:15-10:45 Optimizing Prophylaxis in Resource-Challenged Settings
Speaker:NguyenThi Mai, National Institute of Hematology and Blood Transfusion, Hanoi.		 Lab monitoring for surgery withnon-CFC products
Speaker: Nitty Mathews, Christian Medical College Vellore, Vellore.
10:45-11:15 Tea Break
11:15-12:30 Scientific Session 2a
Theme: Inhibitors in Haemophilia
Chair: Runhui Wu, Children’s Hospital, Capital Medical University, Beijing.		 Scientific Session 2b
Theme: Using registries to improve haemophilia care
Chair: Shashikant Apte, Sahyadri Specialty Hospital, Pune.
11:15-11:40 Prevalence of inhibitors – How toenhance surveillance?
Speaker: Ng HengJoo, Singapore General Hospital, Singapore.		 National registries
Speakers: Japan: Takeshi Matsumoto, Mie University Hospital, Mie Prefecture.
Thailand: Ampaiwan Chuansumrit, Ramathibodi Hospital, Bangkok.
11:40-12:05 Immune Tolerance Therapy for Inhibitors – An Asian Perspective
Speaker: Li Zekun, Children's Hospital, Capital Medical University Beijing.		 Nation Registries
Speakers: South Korea- Jung Woo Han, Yonsie University Health System, Seoul.
Australia- HuyenTran, The Alfred hospital & Monash Medical Centre, Melbourne.
12:05-12:30 Prevention of Bleeds in Persons with Haemophilia with Inhibitors
Speaker:Renchi Yang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin.		 APBDR
Speaker: Azusa Nagao, Ogikubo Hospital, Tokyo.
12:30-13:00 Lunch
13:00-14:00 Sponsored Symposium I- Sanofi Sponsored Symposium II- Roche
Hall A
14:00-14:40 Plenary 2
Chair: Darintr Sosothikul, Chulalongkorn University, Bangkok.
14:00-14:30 Addressing the diagnostic gap in haemophilia and other inherited bleeding disorders - what are the possibilities?
Speaker: Keith Gomez, Royal Free Hospital, London.
14:30-14:40 Discussion
Hall A Hall B
14:45-16:15 Scientific Session 3a – Women with Bleeding Disorders
Chair: Chean Sophal, National Pediatric Hospital, Phnom Penh.		 Scientific Session 3b – Nursing
Chair: Lim Chiew Ying, KK Women’s and Children’s Hospital, Singapore.
14:45-15:15 Womenwith Bleeding Disorders – Diagnostic Issues
Speaker:Tan Chuen Wen, Singapore General Hospital, Singapore.		 Nursing principles of care- bleeding disorders
Speaker: Jamie Chase, John Hunter Childrens Hospital, New South Wales.
15:15-15:45 Management of Menorrhagia in Women with Bleeding Disorders
Speaker: Bundarika Suwanawiboon, Siriraj Hospital, Bangkok.		 Panel Discussion- Role of Haemophilia Nurse in HTCs across Asia Pacific.
Moderator: Abraham Sunder Singh, Christian Medical College, Vellore.
Panelists:
1.Yeam Shin Yen, Singapore General Hospital, Singapore.
2.Pakawan Wongweerawattanakoon, Ramathibodi Hospital, Bangkok.
3.Devika Danekhu, Civil Service Hospital, Kathmandu.
15:45-16:15 Management of Pregnancies and Surgeries in Women with Bleeding Disorders
Speaker: Briony Cutts, Royal Women's hospital Melbourne.		 Training and preparation of a familyfor self-infusion at home.
Speaker: Wu Siting, BeijingChildren's Hospital, Beijing.
16:30-17:00 Moderated poster session with tea
Moderators: Tien SimLeng, Singapore General Hospital, Singapore Rungrote Natesirinilkul, Chiang Mai University, Chiang Mai.
Hall A Hall B
17:00-18:15 Scientific Session 4a – Surgery in haemophilia
Chair: Hideyuki Takedani, National Hospital Organization Tsuruga Medical Center, Fukui.		 Scientific Session 4b – MSK Outcome assessment including PROs
Chair: Judy AnnDavid, Christian Medical College, Vellore.
17:00-17:25 Management of Dental Procedures in Patients with Haemophilia
Speaker: Thanaporn Thongjood, Ramathibodi Hospital, Bangkok.		 MSK Outcomes assessment- Overview
Speaker: Tachit Jiravichitchai, Ramathibodi Hospital, Bangkok.
17:25-17:50 Perioperative haemostasis managementin haemophilia
Speaker: Jae Joon Han, Kyung Hee University, Seoul.		 MSK outcome assessment– what is practical.
Speakers:
a) Taiwan: Yeu-Chin Chen, Tri-Service General Hospital, Taipei.
b) Indonesia: Rizky Kusumawardhani, Dr. Cipto Mangunkusumo Hospital, Jakarta.
5 mins Q&A
c) India: Naveen Cherian Thomas, Christian Medical College, Vellore.
d) Malaysia: Haishini Mageswaran, Hospital Ampang, Ampang.
5 mins Q&A
17:50-18:15 Joint replacement surgery inhaemophilia – What considerations?
Speaker: Shashikant Apte, Sahyadri Specialty Hospital, Pune.
18:15-19:15 Sponsored symposium III with high tea - Takeda Sponsored symposium IV with high tea - Chugai
19:30 Dinner with Invited guests
Time(ICT) HALL A
08:30-09:10 Plenary 3
Chair: Pantep Angchaisuksiri, Ramathibodi Hospital, Bangkok.
08:30-09:00 Non-CFC products for haemophilia –how will they change the management paradigm?
Speaker: Johnny Mahlangu, University of the Witwatersrand, Johannesburg.
09:00-09:10 Discussion
Hall A Hall B
09:15-10:45 Scientific Session 5a – Use of Non-CFC haemostasis products
Chair: Ampaiwan Chuansumrit, Ramathibodi Hospital, Bangkok.		 Scientific Session 5b – Comprehensive Management
Chair: Alison Street, Monash University, Melbourne.
09:15-09:45 Emicizumab – Real world data -Standard & Alternative doses
Speaker: Keiji Nogami, Nara Medical University, Nara.		 Role of WFH in the comprehensive management of haemophilia in the Asia Pacific.
Speakers: Toong Youtananukorn, World Federation of Hemophilia, Montreal.
Hazri Aris, World Federation of Hemophilia, KualaLumpur.
09:45-10:15 The ‘Universal’ haemostasis productsfor haemophilia A/B with and without inhibitors – What can be their impact?
Speaker: Alok Srivastava, Christian Medical College Vellore, Vellore.		 Ultrasoundin clinical decision making - Perspectives & Application
Speaker:Madhavi Kandagaddala, Christian Medical College Vellore, Vellore.
10:15-10:45 Management of Breakthrough Bleeds and Surgery in the Era of Non-CFC Products.
Speaker: Jiaan-Der Wang, Taichung Veterans General Hospital, Taichung.		 Patient Empowerment – Are we doing enough ?
Speaker: Ekawat Suwantaroj, Bangkok.
10:45-11:15 Tea Break
Hall A Hall B
11:15-12:25 Scientific Session 6a – Scientific Abstracts- Physicians and Lab
Moderators: M Joseph John, Christian Medical College, Ludhiana.
Patcharee Kamwilaisak, Khon Kaen University, Khon Kaen.		 Scientific Session 6b – Scientific Abstracts- Nursing and MSK
Moderators: Judy AnnDavid, Christian Medical College, Vellore
Anjalin D’Souza, Manipal Academy of Higher Education, Manipal
11:15-11:20 Introduction Introduction
11:20-11:30 Role of Low Dose prophylaxis of Anti Hemophilic Factor in Haemophilia.
Presenter: Sudipta Nandi, Maulana Azad Medical College, New Delhi.		 Effectiveness of Myofascial therapy (MFT) and Conventional physiotherapy (CPT) with intermittent prophylaxis on Joint Health in Haemophilic Arthropathy- A Proof of Concept Randomized Control Trial.
Presenter: Diksha Sarwan, Christian Medical College and Hospital, Ludhiana.
11:30-11:40 Successful removal of high titer inhibitor in a patient with severe haemophilia A by low dose rituximab combined with low dose FVIII immune tolerance therapy.
Presenter: Li Zhou, The Second Affiliated Hospital of Anhui Medical University, Anhui.		 Estimated cost per bleed saved: On-Demand (OD) versus Low-dose Prophylaxis (LDP) for Indonesian children with Severe Haemophilia A (SHA).
Presenter: Christina Hill-Zabala, Grifols Asia Pacific, Singapore.
11:40-11:50 Barriers to cascade screening and prenatal testing in families with inherited bleeding disorders.
Presenter: Archit Sunil Pandharipande, Post Graduate Institute of Child Health, Noida.		 Out-of-pocket expenditure incurred during treatment of Haemophilia at a government facility in North India.
Presenter: Manju Singh, Post Graduate Institute of Child Health, Noida.
11:50-12:00 Managing surgical procedures in children with inherited bleeding disorders; a single center experience.
Presenter: Eby P Baby, Post Graduate Institute of Child Health, Noida.		 Burden of Care and Quality of Life Among Caregivers of Filipino Children with Haemophilia Before and During the COVID-19 Pandemic: A Cross-Sectional Study.
Presenter: Noah Sacluti, University of Santo Tomas Hospital, Manila.
12:00-12:10 Management of severe haemophilia with inhibitors to factor VIII with recurrent retroperitoneal bleed.
Presenter: Vijayshree Muthukumar, Apollo Hospital, Chennai.		 Rehabilitation for the improvement of functional status in hemophiliacs.
Presenter: Sudipta Nandi, Maulana Azad Medical College, New Delhi.
12:10-12:20 Validation test for Haemophilia self-screening tool In South Kalimantan, Indonesia.
Presenter: Wulandewi Marhaeni, Universitas Lambung Mangkurat, South Kaimantan.		 Sufferings beyond the Physical impact of Haemophilia- A mixed method study on personal, social, economic domains and its association with quality of life in patients with haemophilia (PWH) and their caregivers (WE CARE)
Presenter: Shivani Bhanwra, Christian Medical College and Hospital, Ludhiana.
12:20-12:25 Conclusion Conclusion
12:30-13:00 Lunch
13:00-14:00 Sponsored Symposium V - Novo Nordisk
Hall A
14:00-14:40 Plenary 4
Chair: Ponlapat Rojnuckarin, Chulalongkorn University, Bangkok
14:00-14:30 Radiological assessment of joint –what is possible and what is useful ?
Speaker: Andrea S Doria, The Hospital for Sick Children, Toronto.
14:30-14:40 Discussion
Hall A
14:45-15:45 Scientific Session 7 – Country/Region Presentations
Chair: Theera Ruchutrakool, Siriraj Hospital, Bangkok.
Haemophilia Care
Cambodia: Chean Sophal, National Pediatric Hospital, Phnom Penh.
China: Guoqing Liu, Beijing Children's Hospital, Beijing.
Sri Lanka: Visaka Ratnamalala, National Hospital of Sri Lanka, Colombo.
Bangladesh: Akhil Ranjon Biswas, Dhaka Medical College, Dhaka.
Philippines: Flerida Hernandez, University of Santo Tomas, Manila.
Myanmar: Aye Aye Khaing, Yangon Children Hospital, Yangon.
15:45-16:15 Education and Training - Role of AHAD-AP
Speaker: Alison Street, Monash University, Melbourne.
16:15-17:00 Scientific Session 8 – Hot Topics (Industry presentations)
Chair: Nongnuch Sirachainan, Ramathibodi Hospital, Bangkok.
16:15-16:30 Concizumab prophylaxis in patients with haemophilia A or B without inhibitors: Efficacy and safety results from the primary analysis of the phase 3 explorer8 study.
Speaker: Myriam Dardikh, Novo Nordisk, Dubai.
16:30-16:45 A Phase 3 study (ATLAS-PPX) to evaluate efficacy and safety of fitusiran, an siRNA therapeutic, in people with hemophilia A or B who have switched from prior factor or bypassing agent prophylaxis.
Speaker: Alok Srivastava, Christian Medical College Vellore, Vellore.
16:45-17:00 Phase 3 prospective, randomized, controlled, open-label, multicenter, crossover study of recombinant ADAMTS13 in patients with congenital thrombotic thrombocytopenic purpura.
Speaker: Laura Ochoa, Takeda, Singapore.
17:15-17:30 Closing session
×
×
×
×
×

 


Quick Links

Reach Us

  • Association for Haemophilia and Allied Disorders-Asia Pacific